A new study into the APOE gene suggests two variants may influence Alzheimer's and dementia risk more than previously thought ...
NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. ("DiamiR"), a developer of innovative blood-based diagnostic tests for brain health and ...
Since July 2023, three anti-amyloid medications have been FDA-approved for the treatment of Alzheimer’s disease with more in development. A potential and serious side effect of anti-amyloid ...
Some people have genetic advantages that reduce dementia risk.
Scientists at UCL say drug developers should focus on two risk-raising variants of the Apoe gene ...
NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback